ZINZINO AB (PUBL): PRELIMINARY SALES REPORT FEBRUARY 2019
STRONG SALES GROWTH DURING FEBRUARY; ZINZINO BASED REVENUE INCREASED 21% AND THE TOTAL GROUP REVENUE WITH 18% COMPARED WITH THE PREVIOUS YEAR.
The revenue for Zinzino's sales markets increasing by 21% to SEK 50.1 (41.4) million. Higher share of internal production during the month meant that Faun Pharma's external sales decreased by 22% and amounted to SEK 2.9 (3.7) million. Overall, the Group increased revenues by 18% to SEK 53.0 (45.1) million compared with the previous year.
Accumulated revenues for January-February increased with 16% to 106,5 (91,9) MSEK compared with the previous year.
Revenues distributed as follows:
| Regions, MSEK | Febr-19 | Febr-18 | Change | 2019 | 2018 | Change |
| Nordic Countries | 29.8 | 31.2 | -4% | 60.7 | 61.7 | -2% |
| Baltic States | 4.7 | 3.6 | 29% | 9.0 | 7.3 | 23% |
| Rest of Europa | 13.6 | 5.1 | 168% | 26.6 | 9.4 | 182% |
| North America | 2.0 | 1.5 | 29% | 3.7 | 3.2 | 16% |
| Zinzino | 50.1 | 41.4 | 21% | 100.0 | 81.6 | 23% |
| Faun Pharma | 2.9 | 3.7 | -22% | 6.5 | 10.3 | -37% |
| Zinzino Group | 53.0 | 45.1 | 18% | 106,5 | 91.9 | 16% |
For more information please contact:
Dag Bergheim Pettersen, CEO Zinzino, tel. +47 (0) 932 25 700 www.zinzino.se
Pictures for free publication:
Marcus Tollbom, tel. +46 (0) 70-190 03 12
Certified Adviser:
Erik Penser Bank Aktiebolag: +46 (0)8 463 83 00 Email: certifiedadviser@penser.se
Tags: